Abstract
Cervical cancer is the second most frequent cause of female cancer mortality and remains a major health problem in women worldwide. Surgery, chemotherapy and radiotherapy alone or combined are the three treatments methods commonly used to treat this disease. However, a significant proportion of the cancer patients still experiences recurrence and eventually dies. Recently, the research advances in molecular profiling and genomics have revealed that the phosphatidylinositol 3-kinases (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway plays a crucial role in mediating multiple cellular functions including cell growth, proliferation, metabolism, survival and angiogenesis. Thus, targeting this signal pathway offers a promising perspective for cervical cancer therapy. In this article, we review the published data from both basic and clinical studies showing that the concurrent cervical cancer chemoradiotherapy dramatically improves the local control of this disease and overall survival by triggering tumor cell apoptotic pathways via the PI3K/AKT/mTOR signalings, proving that the PI3K/AKT/mTOR pathway is one of the most important targets for cervical cancer therapy. We also highlight that several phytochemicals strongly inhibit proliferation of the cervical cancer cells and induce apoptosis by targeting one or multiple molecules through the PI3K/AKT/mTOR pathway. While some of these phytochemicals have been used as therapeutic agents or chemoradiotherapy sensitizers, others are currently in clinical development to be the potential therapeutic agents for the advanced cervical cancer therapy.
Keywords: Cervical cancer, chemoradiotherapy, chemoradiosensitizers, growth factors, notch signalings, phytochemicals, PI3K/AKT/mTOR signalings, PI3K inhibitors.
Current Cancer Drug Targets
Title:Phosphatidylinositol 3-kinase Signaling as a Therapeutic Target for Cervical Cancer
Volume: 13 Issue: 2
Author(s): Jianghong Wu, Chen Chen and Kong-Nan Zhao
Affiliation:
Keywords: Cervical cancer, chemoradiotherapy, chemoradiosensitizers, growth factors, notch signalings, phytochemicals, PI3K/AKT/mTOR signalings, PI3K inhibitors.
Abstract: Cervical cancer is the second most frequent cause of female cancer mortality and remains a major health problem in women worldwide. Surgery, chemotherapy and radiotherapy alone or combined are the three treatments methods commonly used to treat this disease. However, a significant proportion of the cancer patients still experiences recurrence and eventually dies. Recently, the research advances in molecular profiling and genomics have revealed that the phosphatidylinositol 3-kinases (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway plays a crucial role in mediating multiple cellular functions including cell growth, proliferation, metabolism, survival and angiogenesis. Thus, targeting this signal pathway offers a promising perspective for cervical cancer therapy. In this article, we review the published data from both basic and clinical studies showing that the concurrent cervical cancer chemoradiotherapy dramatically improves the local control of this disease and overall survival by triggering tumor cell apoptotic pathways via the PI3K/AKT/mTOR signalings, proving that the PI3K/AKT/mTOR pathway is one of the most important targets for cervical cancer therapy. We also highlight that several phytochemicals strongly inhibit proliferation of the cervical cancer cells and induce apoptosis by targeting one or multiple molecules through the PI3K/AKT/mTOR pathway. While some of these phytochemicals have been used as therapeutic agents or chemoradiotherapy sensitizers, others are currently in clinical development to be the potential therapeutic agents for the advanced cervical cancer therapy.
Export Options
About this article
Cite this article as:
Wu Jianghong, Chen Chen and Zhao Kong-Nan, Phosphatidylinositol 3-kinase Signaling as a Therapeutic Target for Cervical Cancer, Current Cancer Drug Targets 2013; 13 (2) . https://dx.doi.org/10.2174/1568009611313020004
DOI https://dx.doi.org/10.2174/1568009611313020004 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Call for Papers in Thematic Issues
Advances in Cancer Biomarkers and Potential Drug Targets: From Diagnosis to Therapy
Cancer biomarkers play a crucial role in the diagnosis, prognosis, and treatment of cancer. They provide valuable information for cancer detection, risk assessment, treatment selection, and monitoring response to therapy. With advancements in molecular biology and high-throughput technologies, there has been an increasing interest in identifying and characterizing cancer biomarkers ...read more
Novel Therapeutic Approaches to Target Drug Resistant Tumors
With the development of disciplines such as chemical biology and molecular biology, the genes or proteins closely related to tumor occurrence and development have gradually become clear. Targeted therapies targeting these genes or proteins provide more effective methods for tumor treatment. Tumor targeted drugs generally only act on specific targets ...read more
ROLE OF IMMUNE AND GENOTOXIC RESPONSE BIOMARKERS IN TUMOR MICROENVIRONMENT IN CANCER DIAGNOSIS AND TREATMENT
Biological biomarkers have been used in medical research as an indicator of a normal or abnormal process inside the body, or of a disease. Nowadays, various researchers are in process to explore and investigate the biological markers for the early assessment of cancer. DNA Damage response (DDR) pathways and immune ...read more
Targeting the battlefield between host and tumor: basic research and clinical practice on reshaping tumor immune microenvironment
Immune system protects host against malignant tumors through effector cells and molecules. Cancer development and its response to therapy are regulated by inflammation, which either promotes or suppresses cancer progression. Chronic inflammation facilitates cancer progression and treatment resistance, whereas induction of acute inflammatory reactions often lead to anti-cancer immune responses. ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Heat Shock Proteins (HSPs): A Novel Target for Cancer Metastasis Prevention
Current Drug Targets Computational Investigation of Zerumbone as an Inhibitor of TNF-alpha Using Molecular Dynamics and Molecular Docking Methods
Letters in Drug Design & Discovery Oral HPV Infection: Current Strategies for Prevention and Therapy
Current Pharmaceutical Design Curcumin in Combined Cancer Therapy
Current Pharmaceutical Design Silence of the Genes: A Targeted Approach to the Suppression of Specific Genes in Human Disease Using Small Interfering RNA (siRNA)
Current Genomics Potential Role of <i>In Vitro-In Vivo</i> Correlations (IVIVC) for the Development of Plant-Derived Anticancer Drugs
Current Drug Targets Ethosomes as Vesicles for Effective Transdermal Delivery: From Bench to Clinical Implementation
Current Clinical Pharmacology Drug Delivery Systems for Prevention and Treatment of Osteoporotic Fracture
Current Drug Targets Magnetite Nanostructures with Applications in Cancer Therapy
Current Proteomics Pharmacological Cyclin-Dependent Kinase Inhibitors (PCIs) as Potential Antiviral Drugs
Anti-Infective Agents in Medicinal Chemistry Role of Chemokines and Their Receptors in Cancer
Current Pharmaceutical Design Molecular Imaging of Therapeutic Potential of Reporter Probes
Current Drug Targets Plant Ribonucleases and Nucleases as Antiproliferative Agens Targeting Human Tumors Growing in Mice
Recent Patents on DNA & Gene Sequences The FDG-PET Revolution of Medical Imaging – Four Decades and Beyond
Current Molecular Imaging (Discontinued) Liposomes as Versatile Platform for Cancer Theranostics: Therapy, Bio-imaging, and Toxicological Aspects
Current Pharmaceutical Design Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs
Current Drug Metabolism Application of Quantum Dots in Drug Delivery
Nanoscience & Nanotechnology-Asia Three-Dimensional Ultrasound in Gynecology: Current Status and Future Perspectives
Current Women`s Health Reviews Estimation of Affinity of HLA-A*0201 Restricted CTL Epitope Based on the SCORE Function
Protein & Peptide Letters Tubulin Maytansine Site Binding Ligands and their Applications as MTAs and ADCs for Cancer Therapy
Current Medicinal Chemistry